Pharming Group N.V.
PHARHealthcare|Biotechnology|NL
$12.29
-0.01 (-0.08%)
DCF Value
$13.58
Tangible Book / Share
$4.05
Graham Number
$0.56
Cash / Share
$2.63
Ownership Breakdown
95.1%
Float
70.8M
Shares Outstanding
67.3M
Float Shares
Major Holders (1)
Combined: 1.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Morgan Stanley | HC, CO | 1.20% | 8,471,801 | Apr 7, 2025 | 13D/G |
Insider Trades (1)
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| CAMDEN PARTNERS STRATEGIC FUND II A LP | other: See General Remarks and FN 1 | May 27, 2004 | AWARD | 5,000 | $0.68 | $3.4K | Form 4 |